v3.26.1
Going Concern (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Dec. 11, 2025
Nov. 14, 2025
Oct. 13, 2025
Jun. 13, 2025
Feb. 27, 2025
May 29, 2024
May 09, 2024
Mar. 20, 2024
Nov. 02, 2023
Sep. 30, 2022
Jan. 31, 2026
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Aug. 06, 2021
Aug. 03, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                    
Cash and cash equivalents                       $ 566,583   $ 5,945,894        
Revolving line of credit                       2,479,490            
Accumulated deficit                       89,729,030   83,873,790        
Net loss                       5,828,522 $ 4,460,464          
Working capital                       $ 6,579,541   $ 10,061,578        
Sale of stock number of shares issued in transaction       3,100,000                     95,000      
Warrants exercisable shares                       3,074,586     190,000      
Exercise price per share       $ 4.50                     $ 4.00      
Issuance of warrant                       7,335,008            
Offering price       3.25                            
Common stock, par value       $ 0.001               $ 0.001   $ 0.001        
Proceeds from issuance of warrants       $ 9,990,000                            
Net issuance cost                       $ 23,234   $ 37,868        
24 Tranche [Member]                                    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                    
Gross proceeds                           9,092,414        
Net issuance cost                           $ 899,997        
Series C Preferred Stock [Member]                                    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                    
Unit share percentage       8.00%                            
Preferred stock, par value       $ 0.001                            
Common Stock [Member]                                    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                    
Net loss                                
Sale of stock number of shares issued in transaction                             237,224      
Exercise price per share                             $ 0.001 $ 0.001    
Common stock registered               770,026 700,000                  
Issuance of warrant 916,000                                  
Shares issuable recorded as liability                     642,000     636,526        
Warrant [Member]                                    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                    
Warrants exercisable shares             700,000               770,026 857,500 344,652 13,091
Exercise price per share $ 2.90       $ 6.502 $ 5.198 $ 5.198               $ 7.40   $ 60.50  
Warrant term         5 years 6 months 5 years 6 months                        
Number of shares issued           1,295,000 1,295,000                      
Issuance of warrant 3,840,421           284,000                      
Shares, Issued         1,424,500                          
Gross proceeds         $ 6,731,000                          
Proceeds from issuance of warrants $ 6,364,000     $ 10,000,000     $ 3,638,000                      
Aggregate number of common shares 2,194,526                                  
Non cash deemed dividend $ 4,485,000       $ 7,602,000   $ 4,996,000                      
Shares issuable recorded as liability 1,278,526           416,000               416,000      
Investor [Member] | Common Stock [Member]                                    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                    
Warrants exercisable shares                 700,000                  
Investor [Member] | Warrant [Member]                                    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                    
Sale of stock number of shares issued in transaction               770,026                    
Warrants exercisable shares                 700,000                  
Exercise price per share               $ 7.40 $ 13.40                  
Warrant term                 5 years 6 months                  
Registered Direct Offering [Member] | Investor [Member]                                    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                    
Proceeds from issuance of equity               $ 2,629,083 $ 4,261,542                  
Registered Direct Offering [Member] | Investor [Member] | Common Stock [Member]                                    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                    
Sale of stock number of shares issued in transaction               237,224 192,500                  
Registered Direct Offering [Member] | Investor [Member] | Pre-funded Warrants [Member]                                    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                    
Sale of stock number of shares issued in transaction               147,789 157,500                  
At The Market Offering Agreement [Member]                                    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                    
Value of shares sold   $ 4,000,000.0               $ 13,000,000.0                
Percentage of gross proceeds from shares                   3.00%                
Sale of stock number of shares issued in transaction     872,027                 1,468,606            
Net proceeds     $ 6,751,381                 $ 2,154,230            
Gross proceeds                       $ 2,232,530            
Warrant Inducement Agreement [Member]                                    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                    
Exercise price per share         $ 0.5198                          
Warrant Inducement Agreement [Member] | Common Stock [Member]                                    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                    
Warrants exercisable shares 916,000       1,295,000                          
Warrant Inducement Agreement [Member] | Warrant [Member]                                    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                    
Warrants exercisable shares 3,840,421       1,295,000                          
Exercise price per share $ 2.90       $ 5.198                          
Warrants exercised         755,558                          
Issuance of warrant         1,295,000                          
Warrants unexercised         539,442                          
Proceeds from issuance of warrants $ 6,364,000                                  
Non cash deemed dividend $ 4,485,000